home / stock / pcsa / pcsa quote
Last: | $9.94 |
---|---|
Change Percent: | -1.58% |
Open: | $9.99 |
Close: | $9.94 |
High: | $9.99 |
Low: | $9.74 |
Volume: | 800 |
Last Trade Date Time: | 09/23/2020 04:54:08 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$9.94 | $9.99 | $9.94 | $9.99 | $9.74 | 800 | 09-23-2020 |
$10.1 | $10.1 | $10.1 | $11 | $10.1 | 2,100 | 09-22-2020 |
$9.39 | $8.19 | $9.39 | $9.39 | $8.19 | 2,280 | 09-21-2020 |
$8.39 | $8.19 | $8.39 | $8.39 | $8.19 | 1,600 | 09-18-2020 |
$8 | $8 | $8 | $8 | $7.805 | 1,500 | 09-17-2020 |
$8.05 | $8.45 | $8.05 | $8.45 | $8.05 | 1,000 | 09-16-2020 |
$8.45 | $8 | $8.45 | $8.45 | $8 | 1,814 | 09-14-2020 |
$7.6 | $7.7 | $7.6 | $7.7 | $7.6 | 200 | 09-08-2020 |
$7.7 | $7.7 | $7.7 | $7.7 | $7.7 | 100 | 09-07-2020 |
$7.7 | $7.7 | $7.7 | $7.7 | $7.7 | 100 | 09-04-2020 |
$8 | $8 | $8 | $8 | $8 | 184 | 09-03-2020 |
$7.95 | $7.95 | $7.95 | $7.95 | $7.95 | 1,050 | 09-02-2020 |
$7.9 | $7.9 | $7.9 | $8 | $7.9 | 302 | 09-01-2020 |
$7.85 | $7.85 | $7.85 | $7.85 | $7.85 | 100 | 08-31-2020 |
$7.8 | $7.8 | $7.8 | $7.8 | $7.8 | 102 | 08-28-2020 |
$8.25 | $8.15 | $8.25 | $8.25 | $8.15 | 200 | 08-27-2020 |
$7.5 | $7.5 | $7.5 | $7.5 | $7.5 | 560 | 08-26-2020 |
$8.18 | $8.18 | $8.18 | $8.18 | $8.18 | 101 | 08-24-2020 |
$8.19 | $8.19 | $8.19 | $8.19 | $8.19 | 250 | 08-21-2020 |
$8.5 | $8.5 | $8.5 | $8.5 | $8.5 | 900 | 07-22-2020 |
News, Short Squeeze, Breakout and More Instantly...
Processa Pharmaceuticals Inc. Company Name:
PCSA Stock Symbol:
OTCMKTS Market:
Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, will be represented at this month’s EF Hutton Annual Global Conference. According to the announcement, ke...
HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, ...
Processa (NASDAQ: PCSA) is a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety. The company today announced that it has named Steven Cha, M.D. as senior vice president of clinical research. In the newly cre...